Cost of the Kansas University Cancer Center is rising to $329 million to include more research laboratories and in response ...

Kansas City will be getting some mass transportation upgrades to support hosting the upcoming FIFA World Cup, according to KCUR. At least 215 more buses will be on Kansas City roads between June and ...

Merck opens $582 million Taiwan plant to strengthen semiconductor materials supply chain. Facility expected to ramp up production in 2026, boosting Asia-Pacific AI chip output. Plant aims to cover 80% ...

Merck & Co Inc. is seeking to raise as much as $8 billion through a corporate bond sale, with part of the proceeds expected to help fund its proposed acquisition of Cidara Therapeutics Inc., according ...

The Trump administration has changed guidance for a federal broadband grant program, urging states to prioritize lower-cost internet projects. Kansas received $451 million for broadband expansion but ...

West Virginia National Guard member dies after being shot in DC attack, Trump says ‘Everybody Loves Raymond’ cast reunites for 30th anniversary special: The stars then and now Border Patrol is ...

KSHB 41 reporter Ryan Gamboa covers Miami County in Kansas and Cass County in Missouri. He also covers agricultural topics. Share your story idea with Ryan. He spent Thanksgiving night on a Kansas ...

Merck (MRK)’s stock surged by 41% over the past six months, driven not significantly by revenue, but rather by increased profits and heightened investor confidence. Following crucial Q3 earnings ...

Forbes contributors publish independent expert analyses and insights. Erik Buchinger is a Forbes college football reporter. Nov 24, 2025, 04:28pm EST NASHVILLE, TENNESSEE - JULY 17: SEC Commissioner ...

Conference commissioners are expecting to receive an extended deadline as they contemplate whether to expand the College Football Playoff in 2026 and beyond, a person familiar with the discussions ...

With a phase 3 win for a combination of its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) and Keytruda, Merck & Co.’s partner Kelun-Biotech is the latest to claim that ...